首页> 外文期刊>Health Economics Review >Macro-level factors impacting geographic disparities in cancer screening
【24h】

Macro-level factors impacting geographic disparities in cancer screening

机译:影响癌症筛查地理差异的宏观因素

获取原文
           

摘要

Objectives Examine how differences in state regulatory environments predict geographic disparities in the utilization of cancer screening. Data sources/setting 100% Medicare fee-for-service population data from 2001-2005 was developed as multi-year breast (BC) and colorectal cancer (CRC) screening utilization rates in each county in the US. Study design A comprehensive set of supply and demand predictors are used in a multilevel model of county-level cancer screening utilization in the context of state regulatory markets. States dictate insurance mandates/regulations and whether alternative providers (nurse practitioners) can provide preventive care services supplied by MDs. Controlling statistically for the supply of both types of providers, we study the joint effects of two private insurance regulations: one mandating that insureds with serious or chronic health conditions may receive continuity of care from their established physician(s) after changing health insurance plans, and another mandating that external grievance review is an option for all health plan coverage/denial decisions. These private insurance plan regulations are expected to affect the degree of beneficial spillovers from managed care practices, which may have increased area-wide cancer screening rates. Principal findings The two private insurance regulations under study were significant predictors impacted by local market conditions. Managed care spillovers in local markets were significantly associated with higher BC screening rates, but only in states lacking the two forms of regulation under study. Spillovers were significantly associated with higher CRC cancer screening rates everywhere, but much higher in the unregulated states. Area poverty dampened screening rates, but less so for CRC screening in the states with these regulations. Conclusions Two state insurance regulations that empowered consumers with more autonomy to make informed utilization decisions varied across states, and exhibited significant associations with screening rates, which varied with the degree of managed care penetration or poverty in the state’s counties. Beneficial spillover effects from managed care practices and negative influences from area poverty are not uniform across the United States. Both variables had stronger associations with CRC than BC screening utilization, as did state regulatory variables. CRC screening by endoscopy was more subject to market and regulatory factors than BC screening. Electronic supplementary material The online version of this article (doi:10.1186/s13561-014-0013-7) contains supplementary material, which is available to authorized users.
机译:目的检查国家监管环境的差异如何预测癌症筛查利用中的地理差异。数据来源/设置2001-2005年100%的Medicare有偿服务人口数据是根据美国每个县的多年期乳腺癌(BC)和大肠癌(CRC)筛查利用率开发的。研究设计在州监管市场的背景下,在县级癌症筛查利用的多级模型中使用了一套全面的供需预测指标。州规定保险的强制性/法规,以及替代提供者(护士)是否可以提供由医师提供的预防性护理服务。从统计学上控制两种医疗服务提供者的供应,我们研究了两项私人保险法规的共同影响:一项强制规定,患有严重或慢性健康状况的被保险人在更改健康保险计划后可能会从其既定的医生那里获得连续的护理,另一个要求外部申诉审查是所有健康计划覆盖/拒绝决定的选项。预计这些私人保险计划法规将影响管理式护理实践对有益溢出的影响程度,这可能会提高全地区的癌症筛查率。主要发现正在研究的两项私人保险法规是受当地市场状况影响的重要预测指标。本地市场中的管理医疗溢出与BC筛查率较高显着相关,但仅在缺乏正在研究的两种监管形式的州中。溢出与各地更高的CRC癌症筛查率显着相关,但在不受管制的州则更高。区域贫困削弱了筛查率,但对于有这些规定的州的CRC筛查却没有那么大。结论两项赋予州消费者更多自治权的州保险法规,各州之间可以做出知情的使用决策,并且与筛查率之间存在显着关联,筛查率随州县医疗管理渗透率或贫困程度的变化而变化。在美国,管理式护理实践产生的有益溢出效应和区域贫困带来的负面影响并不统一。这两个变量与CRC的关联性都比BC筛查利用强,与州监管变量一样。与BC筛查相比,通过内窥镜检查进行CRC筛查更受市场和监管因素的影响。电子补充材料本文的在线版本(doi:10.1186 / s13561-014-0013-7)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号